Edition:
United States

People: Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

192.05USD
8 Sep 2016
Change (% chg)

-- (--)
Prev Close
$192.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
677
52-wk High
$195.20
52-wk Low
$133.25

Soiron, Rolf 

Dr. Rolf Soiron is Chairman of the Board of Directors of Lonza Group Ltd since April 11, 2005. He is Member of the Nomination and Compensation Committee of the Company. From January 24, 2012 to April 30, 2012, he was also Interim Chief Executive Officer of the Company. He is Member of Innovation and Technology Committee. From 2003 to 2010, he served as Chairman of the Board of Directors of Nobel Biocare Holding Ltd. He has been Member of the Board of Directors of Holcim Ltd, since 1994, and its Chairman since 2003. He has been Member of the Board of Directors of Jungbunzlauer Group since 1993. He served as Managing Director of Jungbunzlauer Group from 2001 till 2003. He served as Chief Executive Officer of Jungbunzlauer Group from 1993 till 2001. He served as Chief Operating Officer and Head of Pharma at Sandoz Group, from 1992 till 1993, and as Group Vice-President Agribusiness USA from 1988 till 1992. He served as President and Chief Executive Officer of Protek Group from 1983 till 1987. He held various functions in Human Resources, Finance and Corporate at Sandoz Group from 1982 till 1983. He has been Chairman of the Foundation Council of Avenir Suisse since 2009. Furhermore, he has been Member of the International Committee of the Red Cross since 2009. He has been Member of the Board of economiesuisse since 2009. He has served as Chairman of the Basel University Council from 1995 till 2005. He is Accredited Business Accountant. He holds a Doctorate in Philosophy in History from Universitaet Basel, obtained in 1972, and a Professional Masters Degree (PMD) from Harvard Business School.

Basic Compensation

Total Annual Compensation, CHF 442,117
Restricted Stock Awards, CHF --
Long-Term Incentive Plans, CHF --
All Other, CHF 41,976
Fiscal Year Total, CHF 484,093

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --